Separation and determination of dexamethasone sodium phosphate in cochlear perilymph fluid by liquid chromatography with ultraviolet monitoring and electrospray ionization mass spectrometry characterization.

Hongxia Liu,Xiaolan Chen,Shusheng Zhang,Lingbo Qu,Yufen Zhao,Hongjian Liu,Mingmin Dong
DOI: https://doi.org/10.1016/j.jchromb.2004.03.005
IF: 3.318
2004-01-01
Journal of Chromatography B
Abstract:The method for separation and determination of dexamethasone sodium phosphate (DexP) in cochlear perilymph fluid (CPF) of cavy was developed using HPLC with ultraviolet (UV) monitoring and electrospray ionization/mass spectrometry (ESI/MS) identification. The quantitative determination of DexP in CPF was achieved by HPLC with UV detection at 245nm. The separation was carried out on a Phenomenex ODS(3) column (250mm×4.6mm i.d., 5μm) with the mobile phase of acetonitrile–5mmol/l ammonium acetate (23:77 (v/v)) at a flow rate of 1.0ml/min. DexP was baseline separated from the matrices of CPF blanks within 15min. The linearity ranged from 0.5 to 50μg/ml. The limit of detection was 0.10μg/ml. The recovery ranged from 98.5 to 100.8%. The relative standard deviations (R.S.D.s) of intra- and inter-day peak area were between 0.7–1.3 and 1.2–3.5%, respectively. Both full scan MS and MS2 of DexP with positive and negative polarity were obtained and elucidated. The specific ions were chosen to characterize DexP in the CPF sample. Using the proposed HPLC-UV-ESI/MS method, the concentration of DexP in CPF samples after both vein and middle ear injections were determined, and the relationships between concentration and time were obtained. This method offered reference data for clinical investigation of DexP to cure ear diseases.
What problem does this paper attempt to address?